Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CBUS
Upturn stock ratingUpturn stock rating

Cibus Global LLC (CBUS)

Upturn stock ratingUpturn stock rating
$1.5
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/20/2025: CBUS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

4 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $16.38

1 Year Target Price $16.38

Analysts Price Target For last 52 week
$16.38Target price
Low$1.38
Current$1.5
high$10.77

Analysis of Past Performance

Type Stock
Historic Profit -81.23%
Avg. Invested days 29
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/20/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 72.37M USD
Price to earnings Ratio -
1Y Target Price 16.38
Price to earnings Ratio -
1Y Target Price 16.38
Volume (30-day avg) 4
Beta 1.88
52 Weeks Range 1.38 - 10.77
Updated Date 07/1/2025
52 Weeks Range 1.38 - 10.77
Updated Date 07/1/2025
Dividends yield (FY) -
Basic EPS (TTM) -10.56

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -1994.29%

Management Effectiveness

Return on Assets (TTM) -11.4%
Return on Equity (TTM) -154.98%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 79315187
Price to Sales(TTM) 15.23
Enterprise Value 79315187
Price to Sales(TTM) 15.23
Enterprise Value to Revenue 16.69
Enterprise Value to EBITDA -1.15
Shares Outstanding 48386500
Shares Floating 21785810
Shares Outstanding 48386500
Shares Floating 21785810
Percent Insiders 36.42
Percent Institutions 24.98

Analyst Ratings

Rating 2
Target Price 16.38
Buy 1
Strong Buy 2
Buy 1
Strong Buy 2
Hold 1
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Cibus Global LLC

stock logo

Company Overview

overview logo History and Background

Cibus Global LLC is a biotechnology company focused on gene editing to develop improved crop varieties. Founded in 2001, Cibus has focused on developing a proprietary Rapid Trait Development System (RTDS) gene editing technology. Key milestones include successful development of traits in various crops, partnerships with seed companies, and continued advancement of its technology platform.

business area logo Core Business Areas

  • Trait Development: Developing and licensing novel plant traits using its RTDS technology. These traits are aimed at improving crop yield, disease resistance, and herbicide tolerance.
  • Licensing and Partnerships: Licensing its RTDS technology and traits to seed companies and other agricultural organizations.
  • Seed Production: Producing seeds with the traits developed to sell to farmers.

leadership logo Leadership and Structure

The leadership team includes Peter Beetham (CEO). Cibus has a typical biotech structure with research, development, commercialization, and administrative departments.

Top Products and Market Share

overview logo Key Offerings

  • Trait Developed for Canola: Cibus developed traits for herbicide tolerance for canola. Competitors include Bayer (BAYRY), Corteva (CTVA), and BASF in the herbicide-tolerant trait market. Data on market share is not publically available.
  • Trait Developed for Rice: Cibus is working to provide traits for weed control on Rice that would give farmers increased flexibility with weed control. Competitors include Bayer (BAYRY), Corteva (CTVA), and BASF in the herbicide-tolerant trait market. Data on market share is not publically available.

Market Dynamics

industry overview logo Industry Overview

The agricultural biotechnology industry is driven by the need for improved crop yields, increased disease resistance, and more efficient farming practices. Gene editing technologies are a growing segment within this industry.

Positioning

Cibus is positioned as a technology provider, licensing its gene editing platform and traits to seed companies. Its competitive advantage lies in its RTDS technology, which it claims offers precision and efficiency in trait development.

Total Addressable Market (TAM)

The TAM for agricultural biotechnology is estimated to be over $50 billion. Cibus is positioned to capture a portion of this market by providing its RTDS technology and traits to seed companies, enabling them to develop and market improved crop varieties.

Upturn SWOT Analysis

Strengths

  • Proprietary RTDS technology
  • Experienced leadership team
  • Partnerships with seed companies
  • Potential for recurring revenue through licensing

Weaknesses

  • Limited commercialized products
  • Reliance on partnerships for revenue
  • Regulatory hurdles for gene-edited crops
  • Competition from established players

Opportunities

  • Expanding RTDS technology to new crops
  • Developing new traits to address emerging agricultural challenges
  • Increasing adoption of gene-edited crops
  • Entering new geographic markets

Threats

  • Regulatory changes impacting gene editing
  • Negative public perception of GMOs/gene-edited crops
  • Competition from other gene editing technologies
  • Economic downturn affecting agricultural investment

Competitors and Market Share

competitor logo Key Competitors

  • BAYRY
  • CTVA
  • BASF

Competitive Landscape

Cibus faces competition from established agricultural companies with significant resources and market presence. Its success depends on the superior performance and cost-effectiveness of its RTDS technology compared to existing methods.

Growth Trajectory and Initiatives

Historical Growth: Historical growth data is not publicly available due to Cibus being a private company.

Future Projections: Future projections are not publicly available due to Cibus being a private company, but growth is expected to come from continued advancements to the RTDS technology platform and more partnerships.

Recent Initiatives: Recent initiatives include expanding its RTDS platform, and expanding their canola traits.

Summary

Cibus Global LLC is a private biotechnology company innovating in gene editing for crop improvement using their RTDS technology. Cibus is striving to improve crop yields and enhance agricultural sustainability. The company's reliance on partnerships and regulatory hurdles pose potential challenges. Its continued advancement of the RTDS platform and expansion into new crops will determine its success.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Cibus Global LLC website
  • Industry reports on agricultural biotechnology
  • Publicly available competitor information

Disclaimers:

The information provided is based on publicly available data and may not be entirely accurate due to the private status of Cibus Global LLC. Market share data is estimated and may not reflect the exact figures.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Cibus Global LLC

Exchange NASDAQ
Headquaters San Diego, CA, United States
IPO Launch date 2023-06-01
Co-Founder, Interim CEO, President, COO & Director Dr. Peter R. Beetham B.Sc., Ph.D.
Sector Healthcare
Industry Biotechnology
Full time employees 157
Full time employees 157

Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products. It focuses on trait productivity in the productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients, which enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was founded in 2001 and is headquartered in San Diego, California.